Absorption, metabolism, and functions of β-cryptoxanthin

Nutrition Reviews

Volumn 74, Issue 2, 2016, Pages 69-82

  Burri, Betty J ^a   La Frano, Michael R ^a   Zhu, Chenghao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Bone; Cancer; Vitamin A; cryptoxanthin

Indexed keywords

BETA CRYPTOXANTHIN; RETINOL; ANTIOXIDANT; CAROTENOID; CRYPTOXANTHIN;

ABSORPTION; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BIOAVAILABILITY; BIOSYNTHESIS; BLOOD; BREAST MILK; CANCER PREVENTION; DEGENERATIVE DISEASE; METABOLISM; OSTEOPOROSIS; TISSUE PRESERVATION; VEGETABLE; ANIMAL; BONE; DIET; DRUG EFFECTS; HUMAN; INTESTINE ABSORPTION; NEOPLASMS;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BONE AND BONES; CAROTENOIDS; CRYPTOXANTHINS; DIET; HUMANS; INTESTINAL ABSORPTION; NEOPLASMS; VITAMIN A;

EID: 84961655095     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuv064     Document Type: Article

References (163)

1. United States Department of Agriculture, Agricultural Research Service. National Nutrient Database for Standard Reference, Release 27. Beltsville, MD: USDA Nutrient Data Laboratory. http://www.nal.usda.gov/fnic/foodcomp/search. Accessed May 26, 2015.
2. SELFNutritionData. Foods highest In beta-cryptoxanthin. http://nutritiondata.self. com/foods-000136000000000000000.html. Updated January 2, 2014. Accessed September 2, 2014.
3. Maiani G, Castón MJ, Catasta G, et al. Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res. 2009;53(suppl 2):S194-S218.
4. Namitha KK, Negi PS. Chemistry and biotechnology of carotenoids. Crit Rev Food Sci Nutr. 2010;50:728-760.
5. Boon CS, McClements DJ, Weiss J, et al. Factors influencing the chemical stability of carotenoids in foods. Crit Rev Food Sci Nutr. 2010;50:515-532.
6. Mercadante AZ. Carotenoids in foods: sources and stability during processing and storage. In: C Socaciu, ed. Food Colorants: Chemical and Functional Properties. Boca Raton, FL: CRC Press; 2008:213-240.
7. de Faria AF, Hasegawa PN, Chagas EA, et al. Cultivar influence on carotenoid composition of loquats from Brazil. J Food Compos Anal. 2009;22:196-203.
8. Dhuique-Mayer C, Caris-Veyrat C, Ollitrault P, et al. Varietal and interspecific influence on micronutrient contents in citrus from the Mediterranean area. J Agri Food Chem. 2005;53:2140-2145.
9. Kimura M, Rodriguez-Amaya DB, Yokoyama SM. Cultivar differences and geographic effects on the carotenoid composition and vitamin-A value of papaya. Lebens Wiss Technol. 1991;24:415-418.
10. Xiang J, Nagaya T, Huang XE, et al. Sex and seasonal variations of plasma retinol, a-tocopherol, and carotenoid concentrations in Japanese dietitians. Asian Pac J Cancer Prev. 2008;9:413-416.
11. Granado-Lorencio F, Olmedilla-Alonso B, Blanco-Navarro I, et al. Seasonal variation of serum a- and β-cryptoxanthin and 25-OH-vitamin D3 in women with osteoporosis. Osteoporos Int. 2008;19:717-720.
12. Rodriguez-Amaya D, Kimura M. HarvestPlus Handbook For Carotenoid Analysis. Washington, DC: HarvestPlus; 2004. Technical Monograph Series 2.
13. Rodriguez-Amaya DB. Food carotenoids; analysis, composition and alterations during storage and processing of foods. ForumNutr. 2003;56:35-37.
14. Pugliese A, O'Callaghan Y, Tundis R, et al. In vitro investigation of the bioaccessibility of carotenoids from raw, frozen and boiled red chili peppers (Capsicum annuum). Eur J Nutr. 2014;53:501-510.
15. Ford ES, Gillespie C, Ballew C, et al. Serum carotenoid concentrations in US children and adolescents. Am J Clin Nutr. 2002;76:818-827.
16. Olmedilla B, Granado F, Southon S, et al. Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries. Br J Nutr. 2001;85:227-238.
17. During A, Doraiswamy S, Harrison EH. Xanthophylls are preferentially taken up compared with b-carotene by retinal cells via a SRBI-dependent mechanism. J Lipid Res. 2008;49:1715-1724.
18. Borel P, Lietz G, Goncalves A, et al. CD36 and SR-B1 are involved in cellular uptake of provitamin A carotenoids by Caco-2 and HEK cells, and some of their genetic variants are associated with plasma concentrations of these micronutrients in humans. J Nutr. 2013;143:448-456.
19. Hollander D, Ruble PE Jr. Beta-carotene intestinal absorption: bile, fatty acid, pH, and flow rate effects on transport. Am J Physiol. 1978;235:E686-E691.
20. United States Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington DC:National Academy Press; 2000.
21. Burri BJ, Clifford AJ. Carotenoid and retinoid metabolism: insights from isotope studies. Arch Biochem Biophys. 2004;430:110-119.
22. Burri BJ, Chang JST, Neidlinger TR. β-Cryptoxanthin- and a-carotene-rich foods have greater apparent bioavailability than b-carotene-rich foods in Western diets. Br J Nutr. 2011;105:212-219.
23. de Pee S, West C, Permaesih D, et al. Orange fruit is more effective than are dark-green, leafy vegetables in increasing serum concentrations of retinol and b-carotene in schoolchildren in Indonesia. Am J Clin Nutr. 1998;68:1058-1067.
24. O'Connell OF, Ryan L, O'Brien NM. Xanthophyll carotenoids are more bioaccessible from fruits than dark green vegetables. Nutr Res. 2007;27:258-264.
25. Kim YS, Park CS, Oh DK. Hydrophobicity of residue 108 specifically affects the affinity of human b-carotene 15,15'-monooxygenase for substrates with two ionone rings. Biotechnol Lett. 2010;32:847-853.
26. Dhuique-Mayer C, Amiot-Carlin M. β-Cryptoxanthin from citrus juices: bioaccessibility and uptake by Caco-2 cell culture model. Acta Horticult. 2009;841:129-134.
27. Schweiggert RM, Mezger D, Schimpf F, et al. Influence of chromoplast morphology on carotenoid bioaccessibility of carrot, mango, papaya, and tomato. Food Chem. 2012;135:2736-2742.
28. Dhuique-Mayer C, Borel P, Reboul E, et al. β-Cryptoxanthin from citrus juices: assessment of bioaccessibility using an in vitro digestion/Caco-2 cell culturemodel. Br J Nutr. 2007;97:883-890.
29. Jeffery J, Holzenburg A, King S. Physical barriers to carotenoid bioaccessibility. Ultrastructure survey of chromoplast and cell wall morphology in nine carotenoid- containing fruits and vegetables. J Sci Food Agric. 2012;92:2594-2602.
30. Huang C, Tang Y, Chen C, et al. The bioaccessibility of b-carotene in stir- or deep-fried vegetables in men determined by measuring the serum response to a single ingestion. J Nutr. 2000;130:534-540.
31. Mills JP, Tumuhimbise GA, Jamil KM, et al. Sweet potato b-carotene bioefficacy is enhanced by dietary fat and not reduced by soluble fiber intake in Mongolian gerbils. J Nutr. 2009;139:44-50.
32. Tyssandier V, Lyan B, Borel P. Main factors governing the transfer of carotenoids from emulsion lipid droplets to micelles. Bioch Biophys Acta. 2001; 1533:285-292.
33. von Lintig J. Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism. Ann Rev Nutr. 2010;30:35-56.
34. Thakkar SK, Maziya-Dixon B, Dixon AGO, et al. b-Carotene micellarization during in vitro digestion and uptake by Caco-2 cells is directly proportional to b-carotene content in different genotypes of cassava. J Nutr. 2007;137:2229-2233.
35. Roman MJ, Burri BJ, Singh RP. Release and bioaccessibility of b-carotene from fortified almond butter during in vitro digestion. J Agric Food Chem. 2012;60:9659-9666.
36. Bengtsson A, Brackmann C, Enejder A, et al. Effects of thermal processing on the in vitro bioaccessibility and microstructure of b-carotene in orange-fleshed sweet potato. J Agric Food Chem. 2010;58:11090-11096.
37. During A, Hussain MM, Morel DW, et al. Carotenoid uptake and secretion by CaCo-2 cells: b-carotene isomer selectivity and carotenoid interactions. J Lipid Res. 2002;43:1086-1095.
38. Brown MJ, Ferruzzi MG, Nguyen ML, et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am J Clin Nutr. 2004;80:396-403.
39. Ribaya-Mercado JD, Maramag CC, Tengco LW, et al. Carotene-rich plant foods ingested with minimal dietary fat enhance the total-body vitamin A pool size in Filipino schoolchildren as assessed by stable-isotope-dilution methodology. Am J Clin Nutr. 2007;85:1041-1049.
40. Maramag CC, Ribaya-Mercado JD, Rayco-Solon P, et al. Influence of carotene-rich vegetable meals on the prevalence of anemia and iron deficiency in Filipino schoolchildren. Eur J Clim Nutr. 2010;64:468-474.
41. Floreani A, Baragiotta A, Martines D, et al. Plasma antioxidant levels in chronic choleosatic liver diseases. Aliment Pharmacol Ther. 2000;14:353-358.
42. Breithaupt DE, Weller P,Wolters M, et al. Plasma response to a single dose of dietary β-cryptoxanthin esters from papaya (Carica papaya L.) or non-esterified β-cryptoxanthin in adult human subjects: a comparative study. Br J Nutr. 2003;90:795-801.
43. Wingerath T, Stahl W, Sies H. β-Cryptoxanthin selectively increases in human chylomicrons upon ingestion of tangerine concentrate rich in β-cryptoxanthin esters. Arch Biochem Biophys. 1995;324:385-390.
44. Schweiggert RM, Kopen RE, Villalobos-Gutierrez MG, et al. Carotenoids are more bioavailable from papaya than from tomato and carrot in humans: a randomized cross-over study. Br J Nutr. 2014;111:490-498.
45. Tanumihardjo SA. Mammalian models for understanding the mechanisms of retinol and retinoid actions. In: WHO Technical Consultation on Vitamin A in Newborn Health: Mechanistic Studies. Geneva, Switzerland: World Health Organization; 2012:93-108.
46. Lee CM, Boileau AC, Boileau TW, et al. Review of animal models in carotenoid research. J Nutr. 1999;129:2271-2277.
47. La Frano MR, Zhu C, Burri BJ. Assessment of tissue distribution and concentration of β-cryptoxanthin in response to varying amounts of dietary β-cryptoxanthin in the Mongolian gerbil. Br J Nutr. 2014;111:968-978.
48. Bendich A, Olson JA. Biological actions of carotenoids. FASEB J. 1989; 119:665-668.
49. Olson JA. Serum levels of vitamin A and carotenoids as reflectors of nutritional status. J Natl Cancer Inst. 1984;73:1439-1444.
50. Ribaya-Mercado JD, Holmgren SC, Fox JG, et al. Dietary b-carotene absorption andmetabolism in ferrets and rats. J Nutr. 1989;119:665-668.
51. Gugger ET, Bierer TL, Henze TM, et al. b-Carotene uptake and tissue distribution in ferrets (Mustela putorius furo). J Nutr. 1992;122:115-119.
52. Conlon LE, King RD, Moran NE, et al. Coconut oil enhances tomato carotenoid tissue accumulation compared to safflower oil in the Mongolian gerbil (Meriones unguiculatus). J Am Food Chem. 2012;60:8366-8394.
53. Moran NE, Clinton SK, Erdman JW Jr. Differential bioavailability, clearance, and tissue distribution of the acyclic tomato carotenoids, lycopene and phytoene, in Mongolian gerbils. J Nutr. 2013;143:1920-1926.
54. Sugiera M, Ogawa K, Yano M. Absorption, storage and distribution of β-cryptoxanthin in rat after chronic administration of Satsuma mandarin (Citrus unshiu Marc.). Biol Pharm Bull. 2013;36:147-151.
55. Murphy MM, Barraj LM, Herman D, et al. Phytonutrient intake by adults in the United States in relation to fruit and vegetable consumption. J Acad Nutr Diet. 2012;112:222-229.
56. Talegawkar SA, Johnson EJ, Carithers TC, et al. Carotenoid intakes, assessed by food-frequency questionnaires (FFQs), are associated with serum carotenoid concentrations in the Jackson Heart Study: validation of the Jackson Heart Study Delta NIRI Adult FFQs. Public Health Nutr. 2008;11:989-997.
57. World Health Organization. Food and Agriculture Organization of the United Nations. Vitamin and Mineral Requirements in Human Nutrition. 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
58. Granado F, Olmedilla B, Blanco I, et al. Major fruit and vegetable contributors to the main serum carotenoids in the Spanish diet. Eur J Clin Nutr. 1996; 50:246-250.
59. Matsuda-Inoguchi N, Date C, Sakurai K, et al. Reduction in estimated vitamin A intake induced by new food composition tables in Japan, where vitamin A is taken mostly from plant foods. Internat J Food Sci Nutr. 2006;57:279-291.
60. Turner T, Burri BJ, Jamil KM, et al. The effects of daily consumption of β-cryptoxanthin- rich tangerines and b-carotene-rich sweet potatoes on retinoid and carotenoid concentrations in plasma and breast milk of Bangladeshi women with low retinoid status in a randomized controlled trial. Am J Clin Nutr. 2013; 98:1200-1208.
61. Hodge AM, Simpson JA, Fridman M, et al. Evaluation of an FFQ for assessment of antioxidant intake using plasma biomarkers in an ethnically diverse population. Public Health Nutr. 2009;12:2438-2447.
62. Al-DelaimyWK, Slimani N, Ferrari P, et al. Plasma carotenoids as biomarkers of intake of fruits and vegetables: ecological-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr. 2005;59:1397-1408.
63. McNaughton SA, Marks GC, Gaffney P, et al. Validation of a food-frequency questionnaire assessment of carotenoid and vitamin E intake using weighed food records and plasma biomarkers: the method of triads model. Eur J Clin Nutr. 2005;59:211-218.
64. Patton S, Canfield L, Huston G, et al. Carotenoids of human colostrum. Lipids. 1990;25:159-165.
65. Canfield LM, Clandinin MT, Davies DP, et al. Multinational study of major breast milk carotenoids of healthy mothers. Eur J Nutr. 2003;42:133-141.
66. Schweigert FJ, Bathe K, Chen F, et al. Effect of the stage of lactation in humans on carotenoid levels in milk, blood plasma and plasma lipoprotein fractions. Eur J Nutr. 2004;43:39-44.
67. Chung H-Y, Ferreira ALA, Epstein S, et al. Site-specific concentrations of carotenoids in adipose tissue: relations with dietary and serum carotenoid concentrations in healthy adults. Am J Clin Nutr. 2009;90:533-539.
68. Craft NE, Haitema TB, Garnett KM, et al. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging. 2004;8:156-162.
69. Deuel HJ Jr, Meserve ER, Johnston CH, et al. Reinvestigation of the relative provitamin A potencies of cryptoxanthin and b-carotene. Arch Biochem. 1945; 7:447-450.
70. Johnson RM, Swick RW, Baumann CA. The vitamin A activity of certain carotenoids in the chick. Arch Biochem. 1949;22:122-131.
71. Greenberg SM, Chatterjee A, Calbert CE, et al. A comparison of the provitamin A activity of β-cryptoxanthin in the chick. Arch Biochem. 1950;25:61-65.
72. John J, Kishore GS, Subbarayan C, et al. Metabolism and biological potency of cryptoxanthin in rat. India J Biochem. 1970;7:222-225.
73. Lindquist A, Andersson S. Biochemical properties of purified recombinant human b-carotene 15,15' monooxygenase. J Biol Chem. 2002;277:23942-23948.
74. Amengual J, Wadjaja-Adhi MAK, Rodriguez-Santiago S, et al. Two carotenoid oxygenases contribute to mammalian provitamin A metabolism. J Biol Chem. 2013;288:34081-34095.
75. Mein JR, Dolnikowski GG, Ernst H, et al. Enzymatic formation of apo-carotenoids from the xanthophyll carotenoids lutein, zeaxanthin and β-cryptoxanthin by ferret carotene-9',10'-monooxygenase. Arch Biochem Biophys. 2011;506:109-121.
76. Dela Sena C, Narayanasamy S, Riedl KM, et al. Substance specificity of purified recombinant human b-carotene 15, 15'-oxygenase (BCO1). J Biol Chem. 2013;288:37094-37103.
77. Lietz G, Oxley A, Boesch-Saadatmandi C, et al. Importance of b,b-carotene 15,15'-monooxygenase 1 (BCMO1) and b,b-carotene 9',10'-dioxygenase 2 (BCDO2) in nutrition and health. Mol Nutr Food Res. 2012;56:241-250.
78. Tian R, Pitchford WS, Morris CA, et al. Genetic variation in the b, b-carotene-9', 10'-dioxygenase gene and association with fat colour in bovine adipose tissue and milk. Anim Genet. 2010;41:253-259.
79. West CE, Castenmiller JJ. Quantification of the "SLAMENGHI" factors for carotenoid bioavailability and bioconversion. Int J Vitam Nutr Res. 1998;68:371-377.
80. Lin Y, Dueker SR, Burri BJ, et al. Variability of the conversion of b-carotene to vitamin A in women measured by using a double-tracer study design. Am J Clin Nutr. 2000;71:1545-1554.
81. Hickenbottom SJ, Follett JR, Lin Y, et al. Variability in conversion of b-carotene to vitamin A in men as measured by using a double-tracer study design. Am J Clin Nutr. 2002;75:900-907.
82. Ho CC, de Moura FF, Kim SH, et al. A minute dose of 14C-b-carotene is absorbed and converted to retinoids in humans. J Nutr. 2009;139:1480-1486.
83. Borel P, Moussa M, Reboul E, et al. Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr. 2007;137:2653-2659.
84. Ferrucci L, Perry JR, Matteini A, et al. Common variation in the b-carotene 15,15'- monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet. 2009;84:123-133.
85. Hendrickson SJ, Hazra A, Chen C, et al. b-Carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr. 2012;96:1379-1389.
86. Lietz G, Oxley A, Leung W, et al. Single nucleotide polymorphisms upstream from the b-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr. 2012;142:161S-165S.
87. Wang TT, Edwards AJ, Clevidence BA. Strong and weak plasma response to dietary carotenoids identified by cluster analysis and linked to b-carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms. J Nutr Biochem. 2013;24:1538-1546.
88. Hendrickson SJ, Lindstroem S, Eliassen AH, et al. Plasma carotenoid- and retinolweighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epid Biomark Prev. 2013;22:927-936.
89. Haskell MJ. The challenge to reach nutritional adequacy for vitamin A: b-carotene bioavailability and conversion - evidence in humans. Am J Clin Nutr. 2012;96:1193S-1203S.
90. Van Loo-Bouwman CA, Naber THJ, Schaafsma G. A review of vitamin A equivalency of b-carotene in various food matrices for human consumption. Br J Nutr. 2014;111:2153-2166.
91. La Frano MR, de Moura FF, Boy E, et al. Bioavailability of iron, zinc, and provitamin A carotenoids in biofortified staple crops. Nutr Rev. 2014;72:289-307.
92. Schmaelzle S, Gannon B, Crawford S, et al. Maize genotype and food matrix affect the provitamin A carotenoid bioefficacy from staple and carrot-fortified feeds in Mongolian gerbils (Meriones unguiculatus). J Agric Food Chem. 2014;62:136-143.
93. Davis C, Jing H, Howe JA, et al. β-Cryptoxanthin from supplements or carotenoid- enhanced maize maintains liver vitamin A in Mongolian gerbils (Meriones unguiculatus) better than or equal to b-carotene supplements. Br J Nutr. 2008;100:786-793.
94. Davis CR, Howe JA, Rocheford TR, et al. The xanthophylls composition of biofortified maize (Zea mays Sp.) does not influence the bioefficacy of provitamin A carotenoids in Mongolian gerbils (Meriones unguiculatus). J Agric Food Chem. 2008;65:6745-6750.
95. Arscott SA, Howe JA, Davis CR, et al. Carotenoid profiles in pro-vitamin A-containing fruits and vegetables affect the bioefficacy in Mongolian gerbils. Exp Biol Med (Maywood). 2010;235:839-848.
96. Jamil KM, Brown KH, Jamil M, et al. Daily consumption of orange-fleshed sweet potato for 60 days increased plasma b-carotene concentrations but did not increase total body vitamin A pool size in Bangladeshi women. J Nutr. 2012;142:1896-1902.
97. Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 1995;9:1551-1558.
98. Stahl W, Nicolai S, Briviba K, et al. Biological activities of natural and synthetic carotenoids:induction of gap junctional communication and singlet oxygen quenching. Carcinogen. 1997;18:89-92.
99. Chisté RC, Freitas M, Mercadante AZ, et al. Carotenoids inhibit lipid peroxidation and hemoglobin oxidation, but not the depletion of glutathione induced by ROS in human erythrocytes. Life Sci. 2014;99:52-60.
100. Azqueta A, Collins AR. Carotenoids and DNA damage. Mutat Res. 2012;733:4-13.
101. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191-1308.
102. Gallicchio L, Boyd K, Matanoski G, et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr. 2008;88:372-383.
103. Nishino H, Murakosh M, Ii T, et al. Carotenoids in cancer chemoprevention. Cancer Metastasis Rev. 2009;21:257-264.
104. Chatterjee M, Roy K, Janarthan M, et al. Biological activity of carotenoids: its implications in cancer risk and prevention. Curr Pharm Biotechnol. 2012;13:180-190.
105. Wang L, Li B, Pan MX, et al. Specific carotenoid intake is inversely associated with the risk of breast cancer among Chinese women. Brit J Nutr. 2014;111:1686-1695.
106. Holick CN, Michaud DS, Stolzenberg-Solomon R, et al. Dietary carotenoids, serum b-carotene, and retinol and risk of lung cancer in the Alpha-Tocopherol, Beta-Carotene Cohort Study. Am J Epidemiol. 2002;156:536-547.
107. Albanes D, Heinonen OP, Taylor PR, et al. a-Tocopherol and b-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996;88:1560-1570.
108. Männistö S, Smith-Warner SA, Spiegelman D, et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomark Prev. 2004;13:40-48.
109. Nishino H, Murakoshi M, Tokuda H, et al. Cancer prevention by carotenoids. Arch Biochem Biophys. 2009;483:165-168.
110. Tanaka T, Shnimizu M, Moriwaki H. Cancer chemoprevention by carotenoids. Molecules. 2012;17:3202-3242.
111. Min K, Min J. Serum carotenoid levels and risk of lung cancer death in US adults. Cancer Sci. 2014;105:736-743.
112. Wu C, Han L, Riaz H, et al. The chemopreventive effect of β-cryptoxanthin from mandarin on human stomach cells (BGC-823). Food Chem. 2013;136:1122-1129.
113. Kohno H, Taima M, Sumida T, et al. Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett. 2001;174:141-150.
114. Manabe Y, Hirata T, Sugawara T. Suppressive effects of carotenoids on the antigen- induced degranulation in RBL-2H3 rat basophilic leukemia cells. J Oleo Sci. 2014;63:291-294.
115. Fu H, Wu C, Riaz H, et al. β-Cryptoxanthin uptake in THP-1 macrophages upregulates the CYP27A1 signaling pathway. Mol Nutr Food Res. 2014;58:425-436.
116. San Millán C, Soldevilla B, Martín P, et al. β-Cryptoxanthin synergistically enhances the antitumoral activity of oxaliplatin through DNP73 negative regulation in colon cancer. Clin Cancer Res. 2015;21:4398-4409.
117. Wishart DS, Jewison T, Guo AC, et al. β-Cryptoxanthin (HMDB33844). Human Metabolome Database 3.6. Edmonton, Alberta, Canada: University of Alberta and the Metabolomics Innovation Centre. http://www.hmdb.ca/metabolites/ HMDB33844. Updated January 1, 2015. Accessed December 6, 2015.
118. Katsuura S, Imamura T, Bando N, et al. b-Carotene and β-cryptoxanthin but not lutein evoke redox and immune changes in RAW264 murine macrophages. Mol Nutr Food Res. 2009;53:1396-1405.
119. Matsumoto A, Mizukami H, Mizuno S, et al. β-Cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters in macrophages. Biochem Pharmacol. 2007;74:256-264.
120. Lian F, Hu KQ, Russell RM, et al. β-Cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor b expression. Int J Cancer. 2006; 119:2084-2089.
121. Liu C, Bronson RT, Russell RM, et al. β-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets. Cancer Prev Res. 2011;4:1255-1266.
122. Iskandar, Liu C, Smith DE, et al. β-Cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice. Cancer Prev Res. 2012;6:309-320.
123. Miyazawa K, Miyamoto S, Suzuki R, et al. Dietary β-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice. Oncol Rep. 2007;17:297-304.
124. Narisawa T, Fukaura Y, Oshima S, et al. Chemoprevention by the oxygenated carotenoid β-cryptoxanthin of N-methynitrosourea-induced carcinogenesis in F344 rats. Jpn J Cancer Res. 1999;90:1061-1065.
125. Rondanelli M, Opizzi A, Perna S, et al. Update on nutrients involved in maintaining healthy bone. Endocrinol Nutr. 2013;60:197-210.
126. Yamaguchi M, Uchimaya S. Effect of carotenoid on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro: the unique anabolic effect of β-cryptoxanthin. Biol Pharm Bull. 2003;26:1188-1191.
127. Uchiyama S, Yamaguchi M. Inhibitory effect of β-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol. 2004;67:1297-1305.
128. Yamaguchi M, Uchiyama S. β-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro. Mol Cell Biochem. 2004;258:137-144.
129. Uchiyama S, Ishiyama K, Hashimoto K, et al. Synergistic effect of β-cryptoxanthin and zinc sulfate on the bone component in rat femoral tissues in vitro: the unique anabolic effect with zinc. Biol Pharm Bull. 2005;28:2142-2145.
130. Uchiyama S, Yamaguchi M. β-Cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J Cell Biochem. 2005;95:1224-1234.
131. Uchiyama S, Yamaguchi M. Oral administration of β-cryptoxanthin prevents bone loss in streptozotocin-diabetic rats in vivo. Biol Pharm Bull. 2005; 28:1766-1769.
132. Uchiyama S, Yamaguchi M. β-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells. Int J Mol Med. 2005; 15:671-681.
133. Uchiyama S, Yamaguchi M. β-Cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: change in their related gene expression. J Cell Biochem. 2006;98:1185-1195.
134. Uchiyama S, Yamaguchi M. Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. Int J Mol Med. 2006;17:15-20.
135. Yamaguchi M, Uchiyama S, Ishiyama K, et al. Oral administration in combination with zinc enhances β-cryptoxanthin-induced anabolic effects on bone components in the femoral tissues of rats in vivo. Biol Pharm Bull. 2006;29:371-374.
136. Yamaguchi M, Uchiyama S. Combination of β-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells. Int J Mol Med. 2008;22:221-228.
137. Yamaguchi M, Weitzmann MN. The bone anabolic carotenoid β-cryptoxanthin enhances transforming growth factor-b1-induced SMAD activation in MC3T3 preosteoblasts. Int J Mol Med. 2009;24:671-675.
138. Uchimaya S, Summida T, Yamaguchi M. Anabolic effect of β-cryptoxanthin on bone components in femoral tissues of aged rats in vivo and in vitro. J Health Sci. 2004;50:491-496.
139. Ikeda N, Sugiyama T, Suzuki T, et al. Effects of β-cryptoxanthin on bone metabolism in a rat model of osteoporosis. J Anim Vet Adv. 2012;11:30-35.
140. Matsumoto C, Ashida N, Yokoyama S, et al. The protective effects of β-cryptoxanthin on inflammatory bone resorption in a mouse experimental model of periodontitis. Biosci Biotech Biochem. 2013;77:860-862.
141. Iino M, Kozai Y, Kawamata R, et al. Effects of β-cryptoxanthin on bone-formation parameters in the distal femoral epiphysis of ovariectomized mice. Oral Radiol. 2014;30:1-8.
142. Yamaguchi M. Role of carotenoid β-cryptoxanthin in bone homeostasis. J Biomed Sci. 2012;19:36. doi:10.1186/1423-0127-19-36
143. Sahni S, Hannan MT, Blumberg J, et al. Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study. J Bone Miner Res. 2009;24:1086-1094.
144. Sahni S, Hannan MT, Blumberg J, et al. Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study. Am J Clin Nutr. 2009;89:416-424.
145. Yang Z, Zhang Z, Penniston KL, et al. Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int J Vitam Nutr Res. 2008;78:105-111.
146. Sugiura M, Nakamura M, Ogawa K, et al. Bone mineral density in post menopausal female subjects is associated with serum antioxidant carotenoids. Osteoporos Internat. 2008;19:211-219.
147. Sugiura M, Nakamura M, Ogawa K, et al. Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from postmenopausal Japanese female subjects. Osteopos Internat. 2010;2010:1-10.
148. Sugiura M. Nutritional epidemiologic survey of the relationship between satsuma mandarin intake and the risk for lifestyle-related diseases: Mikkabi Prospective Cohort Study. Jap Soc Food Sci Tech. 2014;61:373-381.
149. Sugiura M, Nakamura M, Ogawa K, et al. Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from postmenopausal Japanese female subjects. Osteo Internat. 2011;22:143-152.
150. Sugiura M, Nakamura M, Ogawa K, et al. High serum carotenoids associated with lower risk for bone loss and osteoporosis in post-menopausal Japanese female subjects: prospective cohort study. PLOS One. 2012;7:e52643. doi:10.1371/ journal.pone.0052643.
151. Ghodratizadeh S, Kanbak G, Beyramzadeh M, et al. Effect of carotenoid β-cryptoxanthin on cellular and humoral response in rabbit. Vet Res Commun. 2014;38:59-62.
152. Fu HF, Wu CJ, Riaz H, et al. β-Cryptoxanthin uptake in THP-1 macrophoges upregulates the CYP27A1 signalling pathway. Mol Nutr Food Res. 2014;58:425-436.
153. Kobori M, Ni YH, Takahashi Y, et al. β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice. PLOS One. 2014;9:e98294. doi:10.1371/journal.pone.0098294.
154. Johnson EJ. Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr Rev. 2014;72:605-612.
155. Aronow ME, Chew EY. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions. Curr Opin Ophthalmol. 2014;25:186-190.
156. Chew EY. Nutrition effects on ocular diseases in the aging eye. Invest Ophthalmol Vis Sci. 2013;54:ORSF42-ORSF47.
157. Koushan K, Rusovici R, Li W, et al. The role of lutein in eye-related disease. Nutrients. 2013;5:1823-1839.
158. Dherani M, Murthy GV, Gupta SK, et al. Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Invest Ophthalmol Vis Sci. 2008;49:3328-3335.
159. Kang JH, Pasquale LR, Willett W, et al. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003;158:337-346.
160. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. Am J Clin Nutr. 1999;69:272-277.
161. Zhou H, Zhao X, Johnson EJ, et al. Serum carotenoids and risk of age-related macular degeneration in a Chinese population sample. Invest Ophthalmol Vis Sci. 2011;52:4338-4344.
162. Chong EW, Wong TY, Kreis AJ, et al. Dietary antioxidants and primary prevention of age-related macular degeneration: systematic review and meta-analysis. BMJ. 2007;335:755. doi:10.1136/bmj.39350.500428.47.
163. Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115:334-341.